3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Plasma cell
1
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Genitourinary
1
Gastrointestinal
1
Classical hematology
1
Breast
1
Conditions
Neoplasms
2
Venous Thrombosis
1
Venous Thromboembolism
1
Vascular Diseases
1
Urogenital Neoplasms
1
Thromboembolism
1
Pulmonary Embolism
1
Prostatic Neoplasms
1
Myeloproliferative Disorders
1
Multiple Myeloma
1
Lymphoproliferative Disorders
1
Lymphoma
1
Lymphatic Diseases
1
Lung Neoplasms
1
Leukemia
1
Intestinal Neoplasms
1
Hemostatic Disorders
1
Digestive System Neoplasms
1
Colorectal Neoplasms
1
Breast Neoplasms
1
Interventions
Blood Specimen Collection
6
Flow Cytometry
4
Psychiatric Rehabilitation
3
Polymerase Chain Reaction
3
Immunoenzyme Techniques
3
Amplified Fragment Length Polymorphism Analysis
3
Watchful Waiting
2
Therapeutics
2
Microarray Analysis
2
edoxaban
1
apixaban
1
X-Rays
1
Valganciclovir
1
Tinzaparin
1
Surveys and Questionnaires
1
Standard of Care
1
Rivaroxaban
1
Reverse Transcriptase Polymerase Chain Reaction
1
Pharmaceutical Preparations
1
Peripheral Blood Stem Cell Transplantation
1
Observation
1
Magnetic Resonance Imaging
1
Influenza Vaccines
1
In Situ Hybridization, Fluorescence
1
Immunosuppression Therapy
1
Immunologic Techniques
1
Gene Expression Profiling
1
Ganciclovir
1
Foscarnet
1
Fentanyl
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Myeloproliferative Disorders
×
Tinzaparin
×
Clear all
NCT03099031
2019-12-16
PREDICARE
LEO Pharma
Completed
420 enrolled